Why is Ajanta Pharma falling/rising?

As of 31-Jul, Ajanta Pharma Ltd. is experiencing a decline in its stock price, currently at Rs 2,740.00, which reflects a decrease of Rs 62.7 or 2.24%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 3.08%. It opened lower today, down 3.29%, and reached an intraday low of Rs 2,710.55. Over the past week, the stock has decreased by 1.96%, while it has shown a positive return of 9.38% over the last month. Despite these recent declines, the company maintains a high management efficiency with a return on equity (ROE) of 22.06% and a low debt-to-equity ratio, which are positive indicators for its financial health. In the broader market context, Ajanta Pharma's short-term performance has lagged behind the benchmark Sensex, which has decreased by 1.22% over the same week. The stock's delivery volume has also fallen significantly, indicating reduced investor participation. However, it has shown consistent returns over the past three years, outperforming the BSE500 in each of the last three annual periods. The stock's high institutional holdings at 26.36% suggest that these investors have the resources to analyze the company's fundamentals, which may provide some support despite the recent price decline.